CLINICAL_TRIALS
trial_result
· 2016-11-22
Clinical Trial Update: Mast-Cell Stabilizing Effects of Olopatadine [Phase 4]
Summary
Phase 4 clinical trial assessing whether olopatadine stabilizes mast cells in allergic conjunctivitis; the study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED